Class information for:
Level 1: ENDOSTATIN//ANGIOSTATIN//COLLAGEN XVIII

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
5596 1535 42.3 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
222 19941 LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ENDOSTATIN Author keyword 307 58% 23% 353
2 ANGIOSTATIN Author keyword 86 50% 8% 125
3 COLLAGEN XVIII Author keyword 65 77% 3% 44
4 TUMSTATIN Author keyword 36 71% 2% 29
5 RECOMBINANT HUMAN ENDOSTATIN Author keyword 35 72% 2% 28
6 ENDOSTAR Author keyword 29 58% 2% 34
7 PLASMINOGEN KRINGLE 5 Author keyword 24 91% 1% 10
8 KNOBLOCH SYNDROME Author keyword 21 78% 1% 14
9 CELL SIGNALING TUMOR ANGIOGENESIS Address 12 86% 0% 6
10 COLLAGEN XV Author keyword 12 86% 0% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ENDOSTATIN 307 58% 23% 353 Search ENDOSTATIN Search ENDOSTATIN
2 ANGIOSTATIN 86 50% 8% 125 Search ANGIOSTATIN Search ANGIOSTATIN
3 COLLAGEN XVIII 65 77% 3% 44 Search COLLAGEN+XVIII Search COLLAGEN+XVIII
4 TUMSTATIN 36 71% 2% 29 Search TUMSTATIN Search TUMSTATIN
5 RECOMBINANT HUMAN ENDOSTATIN 35 72% 2% 28 Search RECOMBINANT+HUMAN+ENDOSTATIN Search RECOMBINANT+HUMAN+ENDOSTATIN
6 ENDOSTAR 29 58% 2% 34 Search ENDOSTAR Search ENDOSTAR
7 PLASMINOGEN KRINGLE 5 24 91% 1% 10 Search PLASMINOGEN+KRINGLE+5 Search PLASMINOGEN+KRINGLE+5
8 KNOBLOCH SYNDROME 21 78% 1% 14 Search KNOBLOCH+SYNDROME Search KNOBLOCH+SYNDROME
9 COLLAGEN XV 12 86% 0% 6 Search COLLAGEN+XV Search COLLAGEN+XV
10 TYPE XV COLLAGEN 11 100% 0% 6 Search TYPE+XV+COLLAGEN Search TYPE+XV+COLLAGEN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANGIOGENESIS INHIBITOR ENDOSTATIN 155 80% 6% 96
2 COLLAGEN XVIII 111 68% 6% 97
3 RECOMBINANT HUMAN ENDOSTATIN 103 56% 8% 124
4 BASEMENT MEMBRANE ZONES 84 80% 3% 52
5 DISTINCT ANTITUMOR PROPERTIES 79 76% 4% 55
6 ANGIOSTATIN 79 34% 12% 191
7 ENDOSTATIN 58 30% 10% 159
8 ANGIOGENESIS INHIBITOR 42 25% 10% 147
9 XVIII COLLAGEN 38 65% 2% 36
10 TUMSTATIN 33 67% 2% 30

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action 2006 303 127 76%
Angiogenesis 2006 707 81 33%
Role of angiogenesis in tumor growth and metastasis 2002 1282 21 38%
The multiple functions of collagen XVIII in development and disease 2011 30 146 79%
Endogenous inhibitors of angiogenesis 2005 293 198 35%
Basement membranes: Structure, assembly and role in tumour angiogenesis 2003 669 183 26%
Tumor stroma derived biomarkers in cancer 2009 49 52 56%
Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents 2014 13 99 26%
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer 2012 18 13 38%
Clinical translation of angiogenesis inhibitors 2002 930 156 19%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CELL SIGNALING TUMOR ANGIOGENESIS 12 86% 0.4% 6
2 AGEN UNIT 6 15% 2.3% 35
3 NANJING STAMOTOL HOSP 4 75% 0.2% 3
4 BEIJING PROT THER EUT 3 23% 0.7% 11
5 TUMOR ANGIOGENESIS 3 42% 0.3% 5
6 CELL SIGNALING ANGIOGENESIS 2 67% 0.1% 2
7 ENGN ANTITUMOR PROT THER EUT 2 24% 0.5% 8
8 CNRS UP A 6021 2 43% 0.2% 3
9 TUMOR TARGETING GRP 2 33% 0.3% 4
10 ICB 4 1 50% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000109478 ANTIANGIOGENIC CANCER VACCINE//CELL PROTEOMIC FOOTPRINTING//HER1 VACCINE
2 0.0000096743 TNP 470//METHIONINE AMINOPEPTIDASE//AGM 1470
3 0.0000095834 LECT2//CHONDROMODULIN I//SHARK CARTILAGE
4 0.0000094706 COUPLING FACTOR 6//DISCOVERY BIOTECHNOL 2//BIOPHARMA
5 0.0000090310 DORN VA MED//TUMOR DORMANCY//CONCOMITANT RESISTANCE
6 0.0000089754 METRONOMIC CHEMOTHERAPY//METRONOMIC//LOW DOSE METRONOMIC CHEMOTHERAPY
7 0.0000081533 ACUTE REJECTION REACTION//TUMOR ANGIOGENESIS//E S 8
8 0.0000080304 FLT 1//VEGF RECEPTORS//VEGF165B
9 0.0000079760 HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP
10 0.0000079419 PLASMA VEGF//MANCHESTER RENAL GRP//PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR